Alpha 2.0
Login Register
» Authors » M Lessmann

M Lessmann

Explore the profile of M Lessmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 8
Followers 0
Related Specialties
Biochemistry
General Medicine
Biology
Top 10 Co-Authors
H K Wasner
H Amini
A Kanellopoulos
J Kros
M E Forster
F Steinberg
M Conrad
F Orsi
W N Kuhn-Velten
E Psarakis
Published In
Biochem Pharmacol
Acta Diabetol
Biochem J
Biol Chem
Adv Exp Med Biol
Affiliations
Soon will be listed here.
Recent Articles
1.
Maximizing agricultural reuse of recycled nutrients: A spatially explicit assessment of environmental consequences and costs
Lessmann M, Kanellopoulos A, Kros J, Orsi F, Bakker M
J Environ Manage . 2023 Feb; 332:117378. PMID: 36736084
Recovering nutrients from organic materials to reduce artificial fertilizer inputs requires the implementation of processing technologies and can involve considerable logistics and transportation costs. Reducing such costs by directly applying...
2.
Degradation of the cyclic AMP antagonist prostaglandylinositol cyclic phosphate (cyclic PIP) by dephosphorylation
Kassner A, Lessmann M, Wasner H
Biol Chem . 1999 Mar; 380(1):85-8. PMID: 10064141
The cAMP antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), is synthesized from prostaglandin E and activated inositol phosphate. From various tissues only that amount of cyclic PIP can be isolated that...
3.
Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes
Wasner H, Lessmann M, Conrad M, Amini H, Psarakis E
Acta Diabetol . 1996 Jul; 33(2):126-38. PMID: 8870815
The endogenous cyclic adenosine monophosphate (AMP) antagonist, cyclic PIP, has been identified as a prostaglandylinositol cyclic phosphate. It inhibits protein kinase A 100% and activates protein serine phosphatase about sevenfold....
4.
Non-invasive infrared-spectroscopic measurements of intravasal oxygen content in xenotransplanted tumours on nude mice--correlation to growth rate
Steinberg F, Lessmann M, Streffer C
Adv Exp Med Biol . 1994 Jan; 345:549-55. PMID: 8079757
No abstract available.
5.
Ketoconazole inhibition of the bifunctional cytochrome P450c17 does not affect androgen formation from the endogenous lyase substrate. The catalytic site remains refractory in the course of intermediary hydroxyprogesterone processing
Kuhn-Velten W, Lessmann M
Biochem Pharmacol . 1992 Dec; 44(12):2371-8. PMID: 1472102
The inhibition of the bifunctional steroidogenic cytochrome P450c17 (CYP17: steroid-17 alpha-hydroxylase/steroid-17,20-lyase) by the imidazole-type fungicide, [(+/-)-cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl- methyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine) (ketoconazole), was investigated with the aim of differentiating between effects on androgen formation...
6.
Specific accumulation of 17 alpha-hydroxyprogesterone in microsomal membranes during the process of cytochrome P-450(C-17)-catalysed androgen biosynthesis. A dynamic study of intermediate formation and turnover
Lessmann M, Forster M, STAIB W
Biochem J . 1988 Nov; 256(1):53-9. PMID: 3223911
A complete dynamic analysis of cytochrome P-450(C-17)-catalysed androgen biosynthesis from a single dose of progesterone and 17 alpha-hydroxyprogesterone in a double-label double-substrate experiment was performed in order to elucidate the...